Evidence map›Paper›PMID 30547062›Full record

ArticleEuropean journal of radiology open2019

1000 consecutive ablation sessions in the era of computer assisted image guidance - Lessons learned.

Marie Beermann, Johan Lindeberg, Jennie Engstrand, Karolina Galmén, Silja Karlgren, David Stillström, Henrik Nilsson, Piotr Harbut, Jacob Freedman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in European journal of radiology open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. CRANE: A Redundant, Multi-Degree-of-Freedom Computed Tomography Robot for Heightened Needle Dexterity within a Medical Imaging Bore.IEEE transactions on robotics : a publication of the IEEE Robotics and Automation Society · 2024
    Article
  7. Article
  8. Quantitative Review of Anesthesia in Liver Tumor Ablation: A Bibliometric Study from 1999 to 2022.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Review
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marie BeermannDept of Radiology, Danderyd University Hospital, Stockholm, Sweden.
Johan LindebergDept of Radiology, Danderyd University Hospital, Stockholm, Sweden.
Jennie EngstrandDept of Surgery and Urology, Danderyd University Hospital, Stockholm, Sweden.
Karolina GalménDept of Anaesthesiology, Danderyd University Hospital, Stockholm, Sweden.
Silja KarlgrenDept of Surgery and Urology, Danderyd University Hospital, Stockholm, Sweden.
David StillströmDept of Surgery and Urology, Danderyd University Hospital, Stockholm, Sweden.
Henrik NilssonDept of Surgery and Urology, Danderyd University Hospital, Stockholm, Sweden.
Piotr HarbutDept of Anaesthesiology, Danderyd University Hospital, Stockholm, Sweden.
Jacob FreedmanDept of Surgery and Urology, Danderyd University Hospital, Stockholm, Sweden.
Danderyds sjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAblation therapies for tumours are becoming more used as ablation modalities evolve and targeting solutions are getting better. There is an increasing body of long-term results challenging resection and proving lower morbidities and costs. The aim of this paper is to share the experiences from a high-volume centre in introducing computer assisted targeting solutions and efficient ablation modalities like microwave generators and irreversible electroporation. MATERIAL AND

methodsOne thousand consecutive treatments in one high-volume centre were evaluated retrospectively from prospectively collected data.

resultsThe purpose of this paper is to present the benefits of going into computer assisted targeting techniques and microwave technology; pitfalls and overview of outcomes. The main target organ was the liver and the main indications were ablation of hepatocellular carcinomas and colorectal liver metastases. With the assistance of computer assisted targeting the local recurrence rate within 6 months has dropped from 30 to near 10%. The survival of patients with hepatocellular carcinoma and colorectal liver metastases is not worse if the tumour can be retreated after a local recurrence. Multiple colorectal liver metastases can be treated successfully. DISCUSSION: The incorporation of computer assisted targeting technologies for ultrasound-, ct guided- and laparoscopic tumour ablation has been very successful and without a noticeable learning curve. The same is true for switching from radiofrequency energies to microwave generators and irreversible electroporation.

conclusionIt is well worthwhile upgrading ablation and targeting technologies to achieve excellent and reproducible results and minimizing operator dependency.

Indexed as

AblationCAS, computer assisted surgeryColorectal liver metastasesFused ultrasoundHepatocellular carcinomaHFJV, high frequency jet ventilationHIFU, high intensity focused ultrasoundIREIRE, irreversible electroporationJet ventilationKidneyLiverLungMicrowaveMWA, microwave ablationPancreasRenal cell carcinomaRFRFA, radio-frequency ablationSBRT, stereotactic body radiation therapyStereotactic navigationTAE, TACE, trans-arterial embolization or chemo-embolizationTIVA, total intravenous anaesthesiaUltrasound

Identifiers

PMID30547062
PMCPMC6282637
OpenAlexW2902351642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.